[7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-thien-2-yl-methanone | 850786-64-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: [7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-thien-2-yl-methanone
• 英文别名: [7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-2-thienyl-methanone；[7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-thiophen-2-ylmethanone
• CAS: 850786-64-0
• 化学式: C₁₇H₁₂N₄OS
• 分子量: 320.374
• InChiKey: BANZONFZSLNTGG-UHFFFAOYSA-N

物化性质

• 密度：
  1.44±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  102
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  [7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-thien-2-yl-methanone 在 盐酸 作用下， 以 甲醇 为溶剂， 反应 0.5h， 生成 [7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-2-thienyl-methanone hydrochloride
  参考文献：
  名称：

  Substituted pyrazolo[1,5-a] pyrimidines and process for making same

  摘要：

  这项发明涉及新型吡唑并[1,5-a]嘧啶化合物及其治疗上可接受的盐。这些化合物在哺乳动物，包括人类中作为抗增殖剂是有用的。

  公开号：

  US20060063785A1
• 作为产物：
  描述：

  (3-氨基吡唑-4-基)(2-噻吩)甲酮 在 铁粉 、 氯化铵 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 生成 [7-(3-aminophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]-thien-2-yl-methanone
  参考文献：
  名称：

  Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel anti-proliferative agents: parallel synthesis for lead optimization of amide region

  摘要：

  A novel series of p21 chemoselective agents containing a pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides were identified by high throughput screening. Optimization of the amide region by parallel synthesis and the iterative design toward understanding structure-activity relationship to improve potency are described. The isopropyl carbamate derivative 34 was identified as a highly chemoselective agent displaying a potency of 51 nM in the p21 deficient cell line. © 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.01.066

文献信息

• Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agents
  作者：Yanong D. Wang、Erick Honores、Biqi Wu、Steve Johnson、Dennis Powell、Miriam Miranda、John P. McGinnis、Carolyn Discafani、Sridhar K. Rabindran、Wendy Cheng、Girija Krishnamurthy

  DOI：10.1016/j.bmc.2008.12.046

  日期：2009.3

  upstream activator, p53, and is associated with poor prognosis in some cancer patients. Using an isogenic pair of cell lines, HCT116 (p21+/+) and 80S14 (p21−/−), we have disclosed previously a novel series of pyrazolo[1,5-a]pyrimidines that preferentially kill the p21-deficient cells. We will present the synthesis, biological activities and SAR study of a series of pyrazolo[1,5-a]pyrimidines with an

  恶性细胞检查点不足可用于开发癌症药物。可以选择性地杀死缺乏检查点的细胞和具有检查点的细胞的化合物来优先靶向肿瘤细胞，同时保留正常细胞。蛋白质p21 Wafl / Cipl / Sdi1（下文称为p21）通过抑制G1激酶（cyclin D / cdk4和cyclin E-cdk2）和G2激酶（cyclin B / cdkl）的活性来抑制细胞周期的进展，以响应DNA损伤或异常DNA含量。由于上游激活因子p53的频繁丢失，人癌细胞中p21的表达通常较低，并且与某些癌症患者的预后不良有关。使用同等基因对的细胞系HCT116（p21 + / +）和80S14（p21-/-），我们先前已经公开了一系列新颖的吡唑并[1,5- a ]嘧啶，可优先杀死p21缺陷型细胞。我们将介绍一系列吡唑并[1,5- a在C-7位置具有优化的苯基酰胺部分的]嘧啶。这些化合物的作用机理也将被讨论。
• Method of using substituted pyrazolo [1,5-a] pyrimidines
  申请人：Wang Daniel Yanong

  公开号：US20060063784A1

  公开（公告）日：2006-03-23

  This invention relates to novel methods of use of certain pyrazolo[1,5-a]pyrimidine compounds and the therapeutically acceptable salts thereof. This invention also relates to novel methods of using these compounds as anti-proliferative agents in mammals, including humans.

  这项发明涉及某些吡唑并[1,5-a]嘧啶化合物及其治疗上可接受的盐的新用途方法。该发明还涉及将这些化合物作为抗增殖剂在哺乳动物，包括人类中的新用途方法。
• Processes for the Preparation of Indiplon and Intermediates Thereof
  申请人：Koilpillai Joseph Prabahar

  公开号：US20120028045A1

  公开（公告）日：2012-02-02

  The present invention relates to processes for the preparation of indiplon and its polymorphic mixtures.

  本发明涉及用于制备indiplon及其多形混合物的过程。
• [EN] METHOD OF USING SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES<br/>[FR] METHODE D'UTILISATION DE PYRAZOLO [1,5-A] PYRIMIDINES SUBSTITUEES
  申请人：WYETH CORP

  公开号：WO2006033795A2

  公开（公告）日：2006-03-30

  This invention relates to novel methods of use of certain pyrazolo[1,5-a]pyrimidine compounds and the therapeutically acceptable salts thereof. This invention also relates to novel methods of using these compounds as antiproliferative agents in mammals, including humans.
• [EN] SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME<br/>[FR] PYRAZOLO [1,5-A] PYRIMIDINES SUBSTITUEES ET LEUR PROCEDE DE FABRICATION
  申请人：WYETH CORP

  公开号：WO2006033796A1

  公开（公告）日：2006-03-30

  This invention relates to novel pyrazolo[1,5-a]pyrimidine compounds and the therapeutically acceptable salts thereof. These compounds are useful as anti­proliferative agents in mammals, including humans.